Ricevi le ultime notizie sulle azioni Iterum Therapeutics con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di ITRM

Ultime notizie per

Iterum Therapeutics

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Iterum Therapeutics PLC

Health Care

Press Releases

Iterum Therapeutics Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares

News

Iterum Therapeutics to Report First Quarter 2025 Financial Results on May 13, 2025

Earnings

Iterum Therapeutics Reports First Quarter 2025 Financial Results

Financing

Iterum Therapeutics Announces Extension of Term of Promissory Note

General

Iterum Therapeutics Announces Partnership for Commercialization Services

Iterum Therapeutics Announces Publication of REASSURE Trial in NEJM Evidence

Management

Iterum Names Christine Coyne as Chief Commercial Officer to Lead ORLYNVAH™ Launch and Commercial Growth

Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Iterum Therapeutics to Report Second Quarter 2025 Financial Results on August 5, 2025

Iterum Therapeutics Reports Second Quarter 2025 Financial Results

ITRM

AN2 Therapeutics

CalciMedica

Cingulate

Clearside Biomedical, Inc. - Common Stock

Clearside Biomedical

Cumberland Pharmaceuticals Inc. - Common Stock

Cumberland

Cadrenal Therapeutics, Inc. - Common Stock

Cadrenal Therapeutics

Durect

Grace Therapeutics

Hyperion DeFi

IGC Pharma

Incannex Healthcare

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

NRX Pharmaceuticals

PolyPid

Rani Therapeutics Holdings, Inc. - Class A Common Stock

Rani Therapeutics Hldgs

Rafael Holdings, Inc. Class B Common Stock

Rafael Holdings

Reviva Pharmaceuticals Holdings, Inc. - Common Stock

Reviva Pharmaceuticals

SCYNEXIS

Sol-Gel Technologies Ltd. - Ordinary Shares

Sol-Gel Technologies

SenesTech

Telomir Pharmaceuticals, Inc. - Common Stock

Telomir Pharmaceuticals

Universe Pharmaceuticals Inc - Ordinary Shares

Universe Pharmaceuticals

Veru

Verrica Pharmaceuticals Inc. - Common Stock

Comments

Iterum Therapeutics Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO